← Back to Search

EHR-based "nudge" interventions for Inappropriate Medications

N/A
Waitlist Available
Led By Jashvant Poeran, MD, PhD
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days post-discharge regarding hospitalization during which a high-risk drug was prescribed
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if changing the default dose settings in electronic prescribing can help doctors choose safer doses for elderly patients. It focuses on hospitalized patients aged 65 and older, aiming to reduce inappropriate prescribing of high-risk drugs.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days post-discharge regarding hospitalization during which a high-risk drug was prescribed
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days post-discharge regarding hospitalization during which a high-risk drug was prescribed for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Prescription rate of modified default dose for eight high-risk drugs
Secondary study objectives
Cost of hospital stay
Drug-specific prescription rate
Length of hospital stay
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
The first option a prescriber sees when prescribing any of eight high-risk drugs for elderly hospitalized patients will be modified; the first frequency option a prescriber sees will be modified as well. Providers retain the ability to prescribe any dose or frequency.
Group II: ControlActive Control1 Intervention
No change in default dose or frequency selected for the eight targeted drugs
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EHR-based "nudge" interventions
2022
N/A
~8640

Find a Location

Who is running the clinical trial?

NYC Health + HospitalsUNKNOWN
3 Previous Clinical Trials
150,652 Total Patients Enrolled
Icahn School of Medicine at Mount SinaiLead Sponsor
903 Previous Clinical Trials
533,127 Total Patients Enrolled
Jashvant Poeran, MD, PhDPrincipal InvestigatorIcahn School of Medicine at Mount Sinai
~2356 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top